Castagnola, E <br/><br/>
Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer.  [electronic resource] 

 -  Journal of chemotherapy (Florence, Italy)  Feb 1999 
 - 54-60 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1120-009X 
<br/><br/><label>Standard No.: </label>10.1179/joc.1999.11.1.54  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Agranulocytosis--drug therapy<br/>Amikacin--administration & dosage<br/>Anti-Bacterial Agents--administration & dosage<br/>Ceftriaxone--administration & dosage<br/>Cephalosporins--administration & dosage<br/>Child<br/>Child, Preschool<br/>Cost Control<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Fever of Unknown Origin--drug therapy<br/>Humans<br/>Infant<br/>Male<br/>Neoplasms--complications<br/>Retrospective Studies<br/>Treatment Outcome